Variable | RIC group (n = 26) | Historical control group (n = 21) | p |
---|---|---|---|
Age, years | 65 (57–81) | 64 (53–77) | 0.692 |
Men, n (%) | 20 (77) | 15 (71) | 0.671 |
APACHE II | 20 (13–23) | 19 (14–23) | 0.932 |
SOFA | 10 (9–12) | 9 (8–12) | 0.104 |
Time after admission, h | 17 (12–23) | 12 (6–20) | 0.159 |
Mortality, n (%) | 12 (46.2) | 12 (57.1) | 0.459 |
Mean arterial pressure, mmHg | 70 (62–78) | 75 (65–86) | 0.202 |
Heart rate, beats/min | 109 (84–121) | 108 (97–125) | 0.638 |
Central venous pressure, mmHg | 10 (7–13) | 12 (10–14) | 0.165 |
Cardiac index, n, L/min m2 | 15, 3.7 (2.8–4.3) | 9, 3.0 (2.5–4.2) | 0.503 |
Norepinephrine dose, n; µg/kg/min | 26; 0.24 (0.12–0.32) | 21; 0.20 (0.12–0.28) | 0.377 |
Arterial lactate, mmol/L | 1.5 (1.2–3.0) | 1.7 (1.4–3.0) | 0.446 |
PaO2, mmHg | 102 (85–144) | 86 (72–140) | 0.441 |
Hemoglobin, g/L | 102 (92–127) | 110 (88–128) | 0.500 |
CRP, mg/L | 262 (151–341) | 221 (133–395) | 0.661 |